Regardless of whether lower SP-D expression in COPD subjects is due to parenchymal destruction, depletion of this protective molecule may still have a substantial effect on subsequent disease progression and susceptibility to infection. The gene discussed is SFTPD; the disease is chronic obstructive pulmonary disease.